26.87000 USD
8.25
44.31%
Last update Dec 10, 2:30 PM GMT
Main market
Day range
26.87000
26.87000
Previous close
18.62000
Open
26.87000
Access this stock data via API
Subscribe
Acadia Pharmaceuticals Inc.
26.87
8.25
44.31%

Financials

Income statement

Fundamentals currency is EUR
Fiscal date Sep 2022 Jun 2022 Mar 2022 Dec 2021
Total reported revenue 374.4M 295.1M 215.5M 189.7M
Cost of revenue 171.8M 136.5M 98M 86.6M
Gross profit 202.6M 158.6M 117.5M 103.1M
Operating expense
Research & development
Selling general and admin 65.8M 7.2M 18.5M -9.3M
Other operating expenses -500K 2M 3.5M 2.1M
Operating income 413.8M -160.8M 362M 70.4M
Non operating interest income
Income 2.9M 3.9M 2.7M 1.5M
Expense 55.3M 50M 31.3M 28.3M
Other income expense
Pretax income 268.6M 431.7M 383.8M 595.9M
Tax provision 42.6M 61.8M 2.9M 105.2M
Net income 226M 369.9M 380.9M 490.7M
Basic EPS 0.0
Diluted EPS 0.0
Basic average shares 8.8B
Diluted average shares 8.8B
EBITDA 364.1M 489.3M 426.8M 638.3M
Net income from continuing op.
Minority interests
Preferred stock dividends -37.9M 37.9M 0 75.1M
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 7 hours 38 minutes

08:51
00:00
08:00
16:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:15 - 08:00
Main market
08:00 - 16:30
Post-market
16:30 - 17:15
All times are displayed in the Europe/London timezone (GMT, UTC+00:00).